A Market Insight into the Progressing and Debatable Market of Stem Cell Research
Posted on: Monday, 23 July 2007, 09:11 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c63408) has announced the addition of "Stem Cell Research" to their offering.
This report analyzes the prevalent stem cell technologies and the therapeutic areas in which stem cells find their applications. The study provides a market insight into the ever progressing and debatable market of Stem Cell Research segmented by type, technology and therapeutic area. Stem Cells by Type are further classified into Adult Stem Cells, Embryonic Stem Cells, and Cord Blood Stem Cells. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, Cell Based Genomics, Xenotransplantation, Cord Blood Banking, and Other. The Therapeutic applications of Stem Cell Research are analyzed by area into Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes, and Other.
Projections and estimates are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 61 major companies are discussed in the report. The report serves as a guide to global Stem Cell industry covering 458 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Exclusive graphical representations are provided for 149 exhibits.
Areas covered:
- Scope And Technology
- Report Synopsis
- Product/Technology Research
- Market Dynamics
- Corporate Directory
For more information visit http://www.researchandmarkets.com/reports/c63408
Source: Business Wire
Related Articles
- Anti-Stem-Cell-Research Ad Ignores Facts
- Global Stem Cell Research Network Approach Key to Therapeutics Success
- BrainStorm Cell Therapeutics Responds to the Veto of the Stem Cell Research Enhancement Act (HR-810)
- Geron Announces Publication of Study Results Supporting Safety and Utility of Human Embryonic Stem Cell-Derived Therapeutic Product for Treatment of Spinal Cord Injury
- Even With Bush Veto, Stem Cell Research Thrives -- Offering Hope for Americans Anticipating Stem Cell-Based Therapies, PrimeCell(TM) Therapeutics Chief Researcher Says
- Geron Presents New Data That Document Progress in Development of Therapeutic Products From Human Embryonic Stem Cells
- Stem Cell Researcher Defends Research
- Singapore Carves Niche in Stem Cell Research
- Scientist to Continue Stem Cell Research
 |
 |
User Comments (0)
RSS Feeds